ArticleInvestigative ophthalmology & visual science2025
Enabling In Vivo Longitudinal Evaluation of Descemet's Membrane Thickness in Wild-type and FECD Mice Using Self-Referenced Optical Coherence Microscopy.
Article in Investigative ophthalmology & visual science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Purpose: Descemet's membrane (DM) remodeling is a key factor in the etiology of early-onset Fuchs endothelial corneal dystrophy (FECD). Although various mouse models have been developed to replicate major FECD phenotypes, including DM thickening, there is currently no imaging technique capable of evaluating changes in mice DM thickness in vivo. This work proposed a novel self-referenced optical coherence microscope (OCM) to longitudinally evaluate age-dependent and FECD-dependent changes in DM thickness in mice. Methods: The self-referenced OCM used the mouse corneal surface as the reference to mitigate artifacts from breathing-induced motion, steep corneal curvature, and dispersion mismatch, that often compromise the delineation of the DM in vivo. The approach was validated by longitudinally evaluating the DM thickness in four wild-type (WT) and five FECD mice at two time points-5 weeks of age and 16 weeks of age. Results: Unlike standard OCM, the self-referenced approach enabled the delineation of the DM with an axial resolution of 1.6 µm in the living eyes of WT and FECD mice. A significant increase in DM thickness was observed in FECD mice (2.74 ± 0.12 µm) compared with WT mice (1.85 ± 0.22 µm) at 5 weeks of age. A similar trend was observed at 16 weeks of age (3.20 ± 0.20 µm in FECD mice vs 2.21 ± 0.32 µm in WT mice). No age-dependent increase in DM thickness was observed in either group between 5 weeks of age and 16 weeks of age. Conclusions: This study represents the first longitudinal in vivo evaluation of age-dependent changes in DM thickness in both WT and FECD mice using self-referenced OCM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.